Q4 2023 OTC Markets Group Inc Earnings Call

Participants

Dan Zinn; General Counsel; OTC Markets Group Inc.

R. Cromwell Coulson; President, Chief Executive Officer, Director; OTC Markets Group Inc

Antonia Georgieva; Chief Financial Officer; OTC Markets Group Inc

Steve Silver; Analyst; Argus Research Corporation

Brendan McCarthy; Analyst; Sidoti & Company, LLC.

Presentation

Operator

Ladies and gentlemen, thank you for standing by, and welcome to OTC Markets Group Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast. At this time, all participants are in a listen only mode. (Operator Instructions)
With that, I would like now to turn the conference over to Dan Zinn, General Counsel. Please go ahead.

Dan Zinn

Thank you, operator. Good morning and welcome to the OTC Markets Group Fourth Quarter and Year End 2023 earnings conference call. With me today are Cromwell Coulson, our President and Chief Executive Officer, and Antonia Georgieva, our Chief Financial Officer.
Today's call will be accompanied by a slide presentation our earnings press release and the presentation are each available on our website. Certain statements during this call and in our presentation may relate to future events or expectations and as such may constitute forward looking statements, actual results may differ materially from these forward-looking statements or information concerning risks and uncertainties that may impact our actual results is contained in the Risk Factors section of our 2023 Annual Report, which is also available on our website for more information, please refer to the Safe Harbor statement on slide 3 of the earnings presentation.
With that, I'd like to turn the call over to Cromwell Coulson.

R. Cromwell Coulson

Thank you, Dan. Good morning, everyone. Thank you for joining us today. I will begin by discussing our year end 2023 results at a high level, and I will review how we performed against our strategic initiatives. I will then discuss our priorities for 2024. Our business achieved record gross revenues of over $109 million for the year. Our results highlight the resilience of our business model as our company-wide performance was supported by a strong revenue increase in our market data licensing business, offset by declines in Corporate Services and OTC Link revenue. The 19% revenue increase in market data reflects the full year impact of our blue sky Data Corp and Edgar Online acquisitions during the prior year.
The onboarding of the EDGAR Online technology stack and dataset involved a large scale effort during 2023, we recognize that we will need to continue integrating and optimizing this business. We view this as a multiyear project. Our team is focused on improving operational efficiency and developing differentiated data products and digital disclosure distribution services, while the corporate services and OTC Link businesses did not meet their high watermarks in a year of lower overall activity across global financial markets.
The work we did to expand our global relationships provides for growth in the years to come. The trend towards international activity continued with trading in non-US companies encompassing the overwhelming majority of dollar volume across our OTCQX OTCQB and pig markets in part due to the increased costs associated with the EDGAR Online integration and operation. Our overall expenses rose 15% during the year. Our expenses were also impacted by a onetime regulatory accrual. These increases in expenses led to decreases in our operating margin and net income as commercial operators. We are committed to sustainable growth over the long term and that focus remains stronger than ever following the results from the past year.
Antonio, we'll cover the details of our financial results in a few moments. Throughout our history, we have made significant investments in market integrity initiatives. We have built out our market surveillance to publicly flagged risks to investors based on disclosure, stock promotion, bankruptcy and other potential public interest concerns. We believe in the value of well lit financial markets to inform investors shine a light on risks that could impact prices and empower our regulators both to oversee markets and enforce rules we provide data and actively make referrals to SCC, Synera and other state and federal agencies.
When companies fail to meet our OTCQX rules and OTCQB standards, we remove them from those markets on a timely basis. While these initiatives are not revenue-generating, we believe they protect investors, incentivize compliance with securities laws and ultimately add value to the overall integrity of the market.
Operating regulated financial market subjects us to oversight from the SEC, Synera and other government agencies. As described further in our 2023 annual report, we have been in discussions with the SEC's Division of Enforcement regarding certain OTC. linked policies and procedures related to the filing of specific suspicious activity reports, we have taken an accrual with the expectation of reaching a settlement with the SEC being a well-regulated market.
Operator makes us a stronger, more resilient organization. We benefit from our interactions with regulators, all the associated inspections, inquiries and reviews ultimately helps us better serve our clients and the industry as a whole, we have an obligation to stay ahead of evolving expectations as we build our compliance programs and supervisory procedures to follow the latter and principles of applicable lead regulations.
As we look back at 2023, several themes emerge, we spent a good portion of the year onboarding personnel technology and data from REOL. acquisitions the previous this year. This data fuels our compliance engines and allows us to fulfill our role as a qualified interdealer quotation system under SEC Rule 15 c. two 11. The acquired datasets also support compliance risk management and market oversight systems at broker-dealers and SROs.
Our results last year showed a good top line increase however, the corresponding growth in expenses kept us from reaching our overall goals throughout 2024, we will pursue the projects and operational improvements that create sustainable revenue growth, meeting this goal requires building scalable processes to provide competitive value and share the benefits of scale with our subscribers, thus driving long-term earnings per share.
During 2024, we will pursue the following strategic priorities. One Team One platform driving results to build the value of one share, continuing to integrate our teams and consolidate our technology platforms to drive operational efficiencies, client value and ultimately revenue growth increased.
The number of securities on our markets continued to grow the size of our markets by adding securities, new asset classes and trading functionality for our broker dealers, subscribers, transform the client connection and improve the quality of information, enhance the client experience through modernized interfaces and enrich data for external and internal users, mitigate operational risk and strengthen regulatory compliance, invest in our core trading infrastructure, operational processes and risk management systems to strengthen our resilience and invest in our regulatory procedures to enhance their reliability and compliance with securities laws and regulations and finally, grow revenue across business lines and align resources with long-term value creation. Can you continue to deliver long-term meaningful shareholder value.
In closing, I'm pleased to announce two important outcome for our March fourth Board meeting. First, I'm delighted to welcome Julia Ceres as the fifth independent director on our Board. Julia is the Chief Digital Officer at Altace power where she oversees the Company's digital and technology strategy and operations and innovation initiatives. Prior to Altace, Julia have held leadership positions at NASDAQ and TA, working with leading technology companies on strategic product launches. We're thrilled to have Julia join us and look forward to her contributions.
I'm also happy to announce that our Board of Directors declared a quarterly dividend of $0.18 per share payable later this month. This dividend reflects our ongoing commitment to providing superior shareholder returns.
With that, I will turn the call over to Antonio.

Antonia Georgieva

Thank you, Cromwell. And thank you, everyone, for joining us today. I would like to start by thanking our entire OTC Markets team for their continued commitment to our subscribers and for driving our business forward.
I will now review our results for the fourth quarter and year ended December 31st, 2023. Any references made to prior period comparatives refers to the fourth quarter or the year ended December 31st, 2022. In 2023, our overall gross revenues, which include a full year of revenues from our blue sky Data Corp and Edgar Online acquisitions increased, but we also experienced increased expenses related to these acquisitions.
Additionally, declines in trading activity and investor engagement on our markets impacted our OTC Link business, while declines in corporate subscribers impacted our corporate services business. Our review of our fourth quarter results is included on page 7. We generated $27.6 million in gross revenues, up 1% as compared to the prior year period. Revenues less transaction-based expenses were up 2% while D teaming. So gross revenues declined 10%, primarily as a result of lower revenue from OTC Link ECN and OTC Link NQB., which in aggregate declined 16% and revenues from our OTC Link ATS messages, which decreased 11% as an offset transaction-based expenses decreased 20%.
The decline in OTC Link revenues and transaction-based expenses was consistent with the decline in trading activity on our markets compared to the fourth quarter of 2022, while DC links finished the fourth quarter with 108 subscribers on OTC Link ECN and 86 subscribers on OTC Link ATS compared to 102 and 87, respectively at the end of the prior year, but the ceiling had 136 unique subscribers to our ATSs at the end of 2023, up three from the end of 2022. Trading volumes remain highly unpredictable and could continue to decline in the future.
Revenues from our Market Data Licensing business were up 10% quarter over quarter, including full quarter contribution from the acquisition of Edgar Online in November 2022, the growth in market data licensing revenues, excluding the impact of EDGAR Online was approximately 7%. Total user accounts were up 6%, driving a 7% increase in the corresponding revenues. Market. Data connectivity fees were up 68% quarter over quarter and revenues from internal system licenses, delayed data licenses and other data services increased 5% in each case, a result of price increases for certain licenses and subscriber growth.
Offsetting these increases was a 22% decline in revenues from non-pro users in line with a 20% decline in the period and nonprofessional user accounts historically and in the normal course of business, we have seen significant changes in the number of nonprofessional users as market volumes and retail participation in the US equity markets fluctuate, and we may experience a further decline in the future.
Corporate Services revenues decreased 1% in the fourth quarter, while DC QX revenues increased 4%, but were offset by a 5% decrease each in revenues from the OTCQB market and the DNS. product. In the fourth quarter, we added 24 OTCQX companies compared to 21 new sales in the prior-year quarter and finished the period with 600 OTCQX companies down 2% on OTCQB.
We added 41 new companies in the fourth quarter compared to 53 in the prior-year period and had 1,144 OTCQB companies at the end of the quarter, down 8%. We had 1,400, 61 being companies subscribing to DNS. and other products at the end of the fourth quarter, down 5%. Month-to-month variability in our corporate services subscribers is driven by new sales offset by non-renewals, corporate events and compliance downgrades.
Turning to page 8, for our full year results. In 2023, we generated gross revenues of $109.9 million, up 5% of the ceiling revenues declined 6% with an 18% decline in the revenues from OTC Link ATS messages and a 5% decline in revenues from OTC Link ECN and OTC Link NQB. as the main drivers, our Market Data Licensing business delivered 19% revenue growth year over year with the benefit the full year revenues from Blue Sky Data Corp. and Edgar Online. Excluding the impact from our acquisitions market data licensing saw approximately 7% revenue growth, driven by the same factors.
As previously mentioned, corporate services revenues decreased 2% with a 3% increase in our OTCQX revenues, mostly due to pricing adjustments, offset by a 3% decline in coal. Do you think you'll be revenues and a 7% decline in GNS revenue, driven by lower average number of companies subscribing to DNS. and LDCQB., respectively.
During 2023, we added 98 new companies to Oxytrex compared to 133 in the prior year and 184 new companies to OTCQB compared to 322 in the prior year for the annual OTCQX subscription period that began on January first, 2023, we achieved a 95% retention rate compared to 96% in the prior year. The retention rate for the annual RBC direct subscription period beginning January 1, 2024, was 93%.
Turning now to expenses on page 9 on a quarter-over-quarter basis, operating expenses increased by 11%. The primary drivers were a 6% increase in compensation and benefits and a 69% increase in professional and consulting fees. The increase in compensation and benefits reflects higher average headcount stemming from our acquisitions, annual base salary increases and an increase in stock-based incentive compensation, partially offset by lower commissions and lower cash-based incentive compensation, compensation and benefits comprised 57% of our total operating expenses during the fourth quarter compared to 59% in the prior-year period. Professional and consulting fees increased primarily due to a 1.2 million accrual related to an SEC matter and approximately 200,000 in related legal and consulting costs on a year-over-year basis.
On page 10, operating expenses were up 15%, driven by similar factors. During 2023. We also incurred approximately $1.1 million in one-time expenses related to EDGAR, online compensation and benefits comprised 62% of our total expense base in 2023 compared to 63% in the prior year.
Turning to page 11, in the fourth quarter, income from operations and net income declined 11% and 19%, respectively. Operating profit margin contracted to 32.8% compared to 37.2% in the prior year. Quarter. For the full year, income from operations declined by 11% and operating margin contracted to 30.6% compared to 36.1% in the prior year.
Net income decreased by 10%, and our diluted earnings per share decreased commensurately to $2.28 per share compared to $2.53 per share in addition to certain GAAP and other measures, Management utilizes adjusted EBITDA, a non-GAAP measure, which excludes non-cash stock-based compensation expenses. Our adjusted EBITDA was $40.9 million for the full year 2023, and our adjusted diluted earnings were $3.37 per share, each down 5% compared to the prior year.
Cash flow from operating activities for 2023 amounted to $33 million and free cash flows were $31.5 million. It's approximately $700,000 lower than in the prior year.
Turning to page 12. During 2023, we returned a total of $29.9 billion to investors in the form of dividends and through our stock buyback program, an increase of 3% over the prior year. We do remain focused on growing our business and delivering long-term value to our stockholders.
And with that, I would like to thank everyone for your time and pass it back to the operator to open the line for questions.

Question and Answer Session

Operator

(Operator Instructions)
Steve Silver, Argus Research Corporation.

Steve Silver

Thank you, operator, and good morning, everybody. Thanks for taking my questions. Trying to get a sense as to as the company thinks about 2024 broadly, just trying to see on your base assumptions, whether revenue growth this year is expected to come more from fee increases from the market, data licensing and corporate services versus expansion of the subscriber bases either from licensing or for them MEMBER expansion on Q. QB?

R. Cromwell Coulson

Thank you, Steve, for your question. We don't give forward expectations. I mean, my my view is that successful companies over the long term drive organic growth and organic growth is going to come from a mix of three. Things is going to come from user and usage growth. It's also going to come from from the value increase to the client that you can that you can reflect in prices and that what I would call stuff in the visible client value is. And then the third is new product development.
And then fourth is acquisitions. Our acquisitions, once you've owned them for a year, they're yours and you need to be using the first three tricks or running them like a Yellow Pages business, which is where you're winding them down and trying to be cost efficient and deliver the service to a declining world.
So international is a big opportunity for us. International across all of our business lines is a big opportunity and all of those support each other more international securities increases volumes across our markets, better engagement disclosure and integration into U.S. broker-dealer compliance processes by those issuers increases, accessibility, investor interest and ultimately, volumes is market data.
The world is globalizing international broker-dealers are wanting to come into the US and trade more around the world, whether they like keeping their money in a U.S. online broker or with a broker in Miami or with a financial advisor in New York or an investment firm in San Francisco or one in Omaha. This is the US is the place where the world invests. So getting our data out there to all these other innovative online brokers around the world.
And what's interesting is the US has led the world in online brokers were the best, but other comp countries and regions are catching up to serve their own markets, which are actually quite small in the first place they connect to as the US. So that's why I'd say we are trying to build for a long term. It's a bit we've never been a business that has straight-line consistent numbers the way Jack Welch used to deliver, gee, we are but we're trying to put in place the sustainable revenue growth is what I would describe it as.

Steve Silver

Okay, that's helpful. Thank you. And one last one, if I may. I know on previous calls, I've asked about the number of, I guess, virtual investor conferences that the company has held. And maybe over the last year or so, it sounded like activity on that front was a little lower just based on pent-up demand for in-person meetings coming out of COVID. Just curious as to whether there's any movement in that front now that the economy seems to be moving much more towards a normalized business-led. Thanks so much.

Antonia Georgieva

Yes, Steve, you're talking about the Peloton problem is, which is everybody did all this virtual stuff during COVID and suddenly which yes and our virtual investor conferences are a key tool. What I would say is the bigger question to really ask is how are Investor Relations Officers changing where they spend their time from pre-COVID to post COVID and becoming more digital. One of our greatest challenges is that in most overseas markets, there's one or two cities where all the investors live and an IRO can go to one of those one or two of those cities and visit all the investors.
Also, there's a pure pretty clear split between institutional money and private clients. The United States is completely different where we have 50 states. There's lots of investment managers all over the place. There's 50 different flavors between institutional and retail and retail.
So if you are an IRO and a senior management team and you're trying to get your story out, there's the valuable two-way conversations with analysts funds that really cover you and your competitors. But there's a lot of other activities that are one-way conversations and those our right for digital. So the in the in the online conference, it is our skill set, but we've gotten past the Peloton moment.
And then now how does it become what part of the use case for public companies as an efficient way to tell your story to a broad audience without having to travel.

Steve Silver

Great. Thank you for that and the best of luck throughout the year.

R. Cromwell Coulson

Thank you, Steve.

Operator

Brendan McCarthy, Sidoti.

Brendan McCarthy

Thanks. Hey, good morning, everybody, and thank you for taking my questions. I just wanted to start off with the regulatory accrual I think you mentioned it was related to the compliance downgrade process, our filing suspicious activity report. Can you go into detail about what I guess what the situation is about?

R. Cromwell Coulson

Good morning, Brendan, and thanks for the question morning. So I'm glad you asked that we can provide a little clarity here. So the discussion that we've been having with the SEC is really related to OTC Link, our broker-dealer business and the policies and procedures and obligations that that that entity has of the broker-dealer from one of those things is the potential for filing suspicious activity reports based on activity on the market and things of that nature.
So that's the the sort of bucket for this regulatory accrual and what that discussion has been about what you're relating it to, though, is kind of what we've been talking about as well, which is our market integrity initiatives overall, all the work that we've been doing for years through the on the OTC Markets Group side of the house and through our surveillance team and our compliance team that deals with the issuers and what we're talking about for the future is really merging those things and being able to drive what we do on the OTC Link side based on a lot of the work that's being done in the OTC Markets Group side.

Brendan McCarthy

And that has been done and for a long time. So there's a kind of a forward-looking focus there about how we're going to get better, how we have gotten better as an organization at merging those things, but it is important to understand what the specific baseline is for the regulatory accrual. I know you probably want to comment here as well?

R. Cromwell Coulson

Yes, subretinal, when we did our market integrity efforts, we've we built them looking at how the exchange SRO.s operated, which was and we did it a little differently because the exchanges are very protective of their brands, so they want them make it look like any company that brings their Bell is this fantastic, exciting Blue Chip investable securities we have and they sell a brand. We have a much broader range of securities. We have OTCQX companies which are not penny stocks. They need to meet financial standards that need to meet governance standards.
They need to be of a certain size to meet the blue-sky standards at a wide range of states. Then we have OTC QB, which is a venture market and eventual market is a public market that gives entrepreneurial and emerging companies, the opportunity to be successful. It's more disclosure driven. There are also standards there.
And finally, we have the pain market, which is often very misunderstood because it exists not for the companies it exists because if you're a shareholder an outside shareholder, you own a property right in the company and a property, right, a security, a share, you've got the right to sell it. So as an outside investor, if you don't like what management is doing, you can sell in the United States.
You have to sell that through a broker-dealer and that broker dealer, if you shop with a security you want to sell or you want to buy your property, which the United States is pretty big about protecting people's rights to property is that broker dealer needs as an agency. Our obligation, which is has been in the law forever to get the best price for their customer.
And so that market develop for distressed companies, companies that were not engaged companies that were financially challenged. Also, companies where controlling shareholders did not have a fiduciary view towards minority investors. So that market was wide, but had a role that is not was almost polar opposite from listing for the companies that list on an exchange, the better quality companies that list on a national securities exchange.
So we developed this process where we would flag risk. And we also, from all the information we received, we would send referrals to regulators. And that's the classic SRO model because our ATS did not have and customers, it was a wholesale utility ATS. We took the Viewpoint mistakenly that we should not be filing source. And that was a mistake because the regulatory view fruit from the SEC side move fit. If they're suspicious activity across our broker-dealer systems, they should file source.
So we're cleaning it up. We're integrating the processes. We are going to move forward in a better place. We have a new CFO, a new CFO sorry, new Chief Compliance Officer. And we have we brought in outside consultants who are ex Securities regulators to review our AML processes and make adjustments. So we are going to come out of this stronger. That's where we are and we have chosen to move forward.
There is another ATS in our space, Archipelago trading services, which there is a public filing by the FCC regard thing which talks further about this from their side, they did not have the market integrity efforts and investment that we've done. However, we are going to fix it and move forward.
Got it.

Brendan McCarthy

Thanks from all. Thank them for the for the insight there. Some sort of kind of fair to assume this is just related to the APS messaging system on with a they bank listed securities.
Yes, John, just the operations of the ATS overall because of that, that's all operated by broker-dealer and therefore covered by the same policy and procedure regulation.
Got it.
Okay. And one more question on the matter. I think $1.4 million expense related to the regulatory accrual and was that all recognized in the fourth quarter Brent and I will tackle that.

Antonia Georgieva

The accrual for the home proposed and expected settlement is $1.2 million. There is an additional approximately $200,000 that we incurred in legal and consulting costs for referring to the consultants that Cromwell will talk about. And so the overall cost is $1.4 million, a portion of it was accrued in the third quarter. However, at that point, the amount was not material and not disclosed as such. And the remainder was accrued in the fourth quarter.
Got it.

Brendan McCarthy

Okay. Just a quick question on the corporate services subscriber base. You I know you mentioned part of the lower subscriber count is driven by non-renewals, corporate events or compliance downgrades. Just wondering if you could provide insight as to which of those was the largest driver of the lower subscriber count in 2023? And what's your expectation there for 2024?

Antonia Georgieva

As we have discussed throughout the year from loans downgrades have been a material driver, have removal from QX and QB from those market tiers during during the year. And largely that was attributed to the more challenging economic environment environment, particularly facing our QB subscribers that tend to be smaller venture stage companies and therefore, more impacted when economic environment is less favorable with rising interest rates and inflation still stronger earlier in the year, albeit thankfully, it's tapering off as we sell more of our QB companies failing to meet the QB standards.
And as Cromwell pointed out, it is our policy to swiftly remove those when from the market tier when they no longer meet those standards, we did see some uptick in compliance downgrades or downgrades down to QB for QS companies as well, more so than in prior years. And similarly on the loan renewal side, we did see an uptick there as well. But certainly the compliance downgrades was the main drivers and brand.
And there's two factors that drive during times of uncertainty. There's downgrades from our markets and there's also downgrades to our markets during in this cycle. We have seen the companies coming off exchanges, not a financial viable number to go to OTCQX or OTCQB.
And that's partially with the environment which we've written about in blog posts of gaining the system with reverse splits and dilutive private placements that continually takes places on the exchanges. So the exchanges have effectively become partially penny stock market and economically distressed companies can stay right till the end. And so they end up in our paint market.

Brendan McCarthy

Got it.
That's very helpful. Maybe one more for me and then I'll jump back into queue. I know I've asked this question on the call previously, and I know remains a multiyear undertaking, but I guess what would you estimate as far as your percentage wise, I guess you're what percent through the EDGAR Online integration is OTC markets credit.

R. Cromwell Coulson

Hopefully, we're at the beginning of forever, and that would be that we can integrate the technology into our systems and and have it be viable going forward and consolidate our datasets and their datasets. That's a lot of work. It's much better to proceed thoughtfully rather than rush rush, but we need to be intentionally moving forward.

Antonia Georgieva

Blue-sky data was an 18 months to a win where we got the technology consolidation. We switch people over to receiving the data from us. We repay but all the contracts we in, we stock much more value into the product by increasing the coverage of securities, and we will be increasing that coverage further. So it was consumed in 18 months and moving forward with it within our within our services. And we were a better organization for it.
And your online has a lot of pieces and it's got datasets that both can be useful for financial analysis by investors and also datasets for USD regulatory compliance. How we integrate both of these platforms is something that needs to be carefully worked through and thought through and staged. So my feeling is we're going to have a good idea where we stand at the end of year three is, is we have this year. He's starting the integrations of a few key datasets, some technology optimizations of how we collect the data. And then there are some consolidations of databases, whether it's securities, master shares outstanding?
Yes, shares outstanding. We collect from various different sources. We have the best shares outstanding database for securities on our markets. We have that because we collected from EDGAR Online through SEC filings. We also collected directly from transfer agents and we collect it from issuers. And that data set of consolidated none that for when people use the EDGAR Online dataset and people use our datasets will take some time to match together. And then there's the optimization is just to make the technology run smoother.
A lot of legacy technology is like driving the car and shift to the bank back Epic mechanics, making it work. However, we need to streamline and just let it do it today is, and then there's a we're working on our Connect project, which is out to issuers that are on our OTCQX and OTCQB market, where as we consolidate one disclosure system and the ability to create standardized financial databases that includes SEC reporting, non-SEC reporting and bank X so we can have the financials for every publicly traded company in the U.S. in an easily searchable and linker able to the original document and that will, we believe, be a useful product can also drive market efficiency.
But this is a it's a lot of pieces and add your online is 10% of our market data revenues. So the premium for sprinting, it's probably not there, but the future for public companies and people who mark that operate public markets is being good at digitalizing the information stream that comes out of the issuers. So supply and demand can interact with fundamental financial information.

Brendan McCarthy

Great.
That's very helpful. Thanks from. Well, one more question, if I may. I'm just looking at the Corporate Services segment. It looks like I was reading the annual report and it looks like the.

R. Cromwell Coulson

Yes, there were a good amount of large international companies that subscribe to QX and you see that very positively. And I think it speaks to the value proposition there. But just curious as to what's your outlook on the overall IPO market for 2024?

Antonia Georgieva

Brent, I hope it is huge, but will survive if it isn't. I mean, the way I look at it is there's a lot of chatter for international markets about the valuations that are not the same valuation you get in the U.S., some of those, some of that, that is because those companies or countries have lower growth rates. However, there is nothing stopping and higher ROE at an international company of doing everything that our New York Stock Exchange or NASDAQ listed international company. IRO. does that hasn't R-LA.
And part of that part of that should be joining the OTCQX. If you can qualify, it's an easy win. It's incredibly efficient because it's 12 G. three to be you want to be in compliance with 12 G. three to be if you're an international company, you want to be in compliance with 10b-5. It's really efficient if you're using your disclosure that you've done for your home market and you want to drive that and that disclosure, those news releases, the compliance in formation into the US market and then you want to do the other things that supported such as if you're a large international health care company, you're going to want to go to the JPMorgan Healthcare Conference and you're going to want to stand on a stage with your global competitors and comparable businesses.
You can't just show up in the U.S. with your countrymen because then you then your peers are also lower valuation companies and you need to run your business to be competitive and offer comparable financial returns. And if you stand on a stage and your business is just as good as the U.S. peers. Investors love buying securities and they are at a discount, but you need to get out there. And whether JPMorgan healthcare or Cowen's conference, if you are a smaller company. And across all these different industries, you need to make your comparable, not just be your countrymen but your competitors and the global leaders in your industry.
Great.

Brendan McCarthy

And thanks, everybody, for the answers. I really appreciate it. That's all for me.

Operator

(Operator Instructions)
I would like to turn the call over to Dan for any additional questions that have been submitted.

Dan Zinn

Thank you, operator. Yes, we did have one question submitted. So I'm going to pose it to Cromwell in the voice of the investor. And given the recent approval of spot crypto ETFs, how does this affect OTC markets Group's business given the high level of trading volume of crypto currency trust assets on OTC, I understand the digital assets have been approved for OTC trading, but is this a near term risk.
The important part about running a broad-based market is no one security is your is your overall business. TBTC. was a fantastic story and listing on exchanges. Was also a fantastic story and a couple of dynamics took place when they upgraded to the New York Stock Exchange. Number one, regulators allowed the issuance cancellation. We would really like regulators to allow issuance and cancellation when this security traded in the OTC market. If the SEC was concerned about market efficiency, they would have it didn't happen.
The second part came in was competition arrived and thus the lower cost of holding these assets in securities, Robert, that would have been great to happen on the OTC market.
And then the third is they were listed on a national securities exchange. So that has been a great success story, too, because a lot of regulatory accessibility shows up and the brands of the exchanges that created a nice bull market again in crypto assets. So we're proud of what we did to support GBTC. and competitors who showed up in the OTC market and the success of this class of assets. We see ourselves our role as a gateway market that what GBTC. can do, many others can do on our markets with innovative industries. So that part of it strengthens our system over the long term.
Now the other side is our ATSs all file with with Fentora transactions. Nobody in the in the OTC space looks at share volume. They look at transaction counts and you can see that we benefit more from active markets than one security. And how do we broaden our base add new securities, Digital Asset Securities. We have a license to put them on our ATS.
The other key players within the regulated securities market do not exist yet. We will be ready. We are having conversations both with the industry and regulators until a broker dealer is able to hold a digital asset security in a way that works for regulators, Omni bus clearing. And this is a really important thing. Accountants, they don't have to take it as a liability on their balance sheet. This this industry is going to be slow to develop but we will be ready when it shows up.

Operator

I show no further questions at this time. I would now like to turn the call back Cromwell Colson for closing remarks.

R. Cromwell Coulson

Thank you, operator. I want to thank each of you for joining us today. I would encourage you to read our full 2023 Annual Report and the earnings press release for more information links to both our available on the Investor Relations page of our website. On behalf of the entire team, we look forward to updating you on our key initiatives that will continue to shape. It's geography, efficiency and competitiveness of the public markets.

Operator

This concludes today's conference call. Thank you for your participation. You may now this.